BBIO:NASDAQ, BridgeBio Pharma, Inc.

BBIO stock overview

BridgeBio Pharma, Inc. (BBIO:NASDAQ) closed at $66.39 on October 16, 2026, down 1.10% on the day. The stock trades 28.9% below its 52-week high of $93.42 and 25.9% above its 52-week low of $52.75. Over the past year, it gained 20.9%. BridgeBio Pharma, Inc. is part of the Health Care sector (Major Pharmaceuticals).

Key figures

Price
$66.39
Day change
-1.10%
Volume
2,055,506
Average volume
2,385,279
Market cap
12B+
52-week range
$52.75 – $93.42
50-day average
$73.27
200-day average
$73.13

Performance

5D 1M 3M 6M 1Y
+0.97% -1.37% -17.79% -13.42% +20.88%

Price action over the past year

In 252 trading sessions since October 16, 2025, BBIO closed higher on 119 days (47%). Its best day was October 27, 2025 (+17.14%) and its worst was February 5, 2026 (-15.24%). The stock moved 10% or more in a single session 4 times. It opened at least 5% above the previous day's high 4 times.

Recent signals

BBIO news

About BridgeBio Pharma, Inc.

BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Oncology and Gene therapy.

Similar stocks

Find more stocks like BBIO with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.